301 related articles for article (PubMed ID: 38529039)
1. Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.
Wißfeld J; Abou Assale T; Cuevas-Rios G; Liao H; Neumann H
Front Neurol; 2024; 15():1330874. PubMed ID: 38529039
[TBL] [Abstract][Full Text] [Related]
2. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
3. Roles of Siglecs in neurodegenerative diseases.
Siew JJ; Chern Y; Khoo KH; Angata T
Mol Aspects Med; 2023 Apr; 90():101141. PubMed ID: 36089405
[TBL] [Abstract][Full Text] [Related]
4. Targeting sialylation to treat central nervous system diseases.
Lünemann JD; von Gunten S; Neumann H
Trends Pharmacol Sci; 2021 Dec; 42(12):998-1008. PubMed ID: 34607695
[TBL] [Abstract][Full Text] [Related]
5. Sialometabolism in Brain Health and Alzheimer's Disease.
Rawal P; Zhao L
Front Neurosci; 2021; 15():648617. PubMed ID: 33867926
[TBL] [Abstract][Full Text] [Related]
6. Siglecs in Brain Function and Neurological Disorders.
Siddiqui SS; Matar R; Merheb M; Hodeify R; Vazhappilly CG; Marton J; Shamsuddin SA; Al Zouabi H
Cells; 2019 Sep; 8(10):. PubMed ID: 31546700
[TBL] [Abstract][Full Text] [Related]
7. Sialylation acts as a checkpoint for innate immune responses in the central nervous system.
Klaus C; Liao H; Allendorf DH; Brown GC; Neumann H
Glia; 2021 Jul; 69(7):1619-1636. PubMed ID: 33340149
[TBL] [Abstract][Full Text] [Related]
8. Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs).
Mitic N; Milutinovic B; Jankovic M
Dis Markers; 2012; 32(3):187-94. PubMed ID: 22377735
[TBL] [Abstract][Full Text] [Related]
9. Microglial Lectins in Health and Neurological Diseases.
Siew JJ; Chern Y
Front Mol Neurosci; 2018; 11():158. PubMed ID: 29867350
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Lustig M; Chan C; Jansen JHM; Bräutigam M; Kölling MA; Gehlert CL; Baumann N; Mester S; Foss S; Andersen JT; Bastian L; Sondermann P; Peipp M; Burger R; Leusen JHW; Valerius T
Front Immunol; 2023; 14():1178817. PubMed ID: 37346044
[TBL] [Abstract][Full Text] [Related]
11. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
12. Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration.
Puigdellívol M; Allendorf DH; Brown GC
Front Cell Neurosci; 2020; 14():162. PubMed ID: 32581723
[TBL] [Abstract][Full Text] [Related]
13. The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy.
Feng H; Feng J; Han X; Ying Y; Lou W; Liu L; Zhang L
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254780
[TBL] [Abstract][Full Text] [Related]
14. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
Brinkman-Van der Linden EC; Varki A
J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
[TBL] [Abstract][Full Text] [Related]
15. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
[TBL] [Abstract][Full Text] [Related]
16. Control of Innate Immunity by Sialic Acids in the Nervous Tissue.
Liao H; Klaus C; Neumann H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752058
[TBL] [Abstract][Full Text] [Related]
17. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.
Wang X; Liu M; Zhang J; Brown NK; Zhang P; Zhang Y; Liu H; Du X; Wu W; Devenport M; Tao W; Mao-Draayer Y; Chen GY; Chen YE; Zheng P; Liu Y
Cell Metab; 2022 Aug; 34(8):1088-1103.e6. PubMed ID: 35921817
[TBL] [Abstract][Full Text] [Related]
18. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
Gianchecchi E; Arena A; Fierabracci A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
[TBL] [Abstract][Full Text] [Related]
19. Siglec functions of microglia.
Linnartz-Gerlach B; Kopatz J; Neumann H
Glycobiology; 2014 Sep; 24(9):794-9. PubMed ID: 24833613
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
